Asymmetric Synthesis Of Cardiovascular Drug Precursor (L-Homophenylalanine) Via Integrated Enzymatic Membrane Bioreactor

Loading...
Thumbnail Image
Date
2011-12
Authors
Oh, Pei Ching
Journal Title
Journal ISSN
Volume Title
Publisher
Universiti Sains Malaysia
Abstract
Over the past decade, L-homophenylalanine (L-HPA) is extensively used in the pharmaceutical industry, as a precursor for production of angiotensin-converting enzyme (ACE) inhibitor. which processes significant clinical application in the management of hypertension and congestive heart failure (CHF). A number of chemical methods have been reported thus far for the synthesis of L-HPA. However, chemical methods generally suffer from process complexity, high cost, and environmental pollution. On the other hand, enantiomerically pure L-HPA can be synthesized elegantly and efficiently by employing biocatalytic methods. Where it appears to be the most attractive process in terms of potential industrial applications, green chemistry and sustainability.
Description
Keywords
Synthesis of cardiovascular drug precursor , via integrated enzymatic membrane bioreactor
Citation